The introduction of new treatment methods has significantly improved the survival rate of breast cancer patients.

Breast cancer diagnosis, treatment, management, trastuzumab, WHO, radiotherapy, surgery, chemotherapyCancer patients are at a higher risk of contracting Covid-19 because their immune system can be compromised.

Experts have revealed that the COVID-19 epidemic followed by repeated lockdowns has negatively affected the diagnosis, treatment and management of breast cancer.

“Even after the many advances in cancer research, prevention and treatment, the world is still battling the burden of cancer. At present, the world is going through a cancer pandemic where one in 10 Indians is expected to develop cancer during his lifetime. The situation is evolving, and there will be a need to take practical action to deal with the challenges of treating patients, while ensuring their safety and well-being,” the experts suggested.

Speaking about the scenario, Dr. Atul Batra, Associate Professor, Department of Medical Oncology, AIIMS, Delhi said: “Among women, the total incidence of cancer was estimated at 712,758 in 2020 and is likely to reach 806,218 by 2025. In fact, it is expected that Breast cancer will be the most common site of cancer by 2025. Cancer treatment options have expanded The use of Trastuzumab (benefits for approximately 3000 patients) and ado-trastuzumab emtansine (benefits for more than 1,700 patients) in India has proven to be a boon in treatment outcomes. This innovative drug is backed by years of clinical data.”

During Covid-19, women with breast cancer have continued to pay the price due to the impact of the pandemic. Therefore, early treatment of symptomatic patients should be a priority, experts suggest adding that in severe cases, late diagnosis can lead to fatal outcomes.

Dr. Sinath Bhatanaputla, Senior Consultant, Care Hospitals, Hyderabad said: “Currently, women with this disease have more treatment options than in the past and can be treated. Treatments are radiotherapy, surgery or both. Chemotherapy is often used as an add-on treatment. And a new assistant and assistant,”

Covid-19 has changed breast cancer care around the world. It has also delayed many aspects of breast cancer care, including routine clinical visits, surveillance imaging, routine mammography, reconstruction, radiotherapy, hormonal therapy, mastectomy, and chemotherapy. The lack of in-person visits to oncologists and the fear of contracting Covid-19 have caused stress and anxiety in patients. This sometimes resulted in discontinuation of the current treatment regimen and an increase in the severity of the disease.

Cancer patients are at a higher risk of contracting Covid-19 because their immune system can be compromised. Therefore, various healthcare facilities of all types and scales are taking new steps to prevent patients and staff from contracting Covid-19.

Some breast cancer treatments can weaken the immune system and the patient becomes more immunocompromised, which can also lead to lung problems. People with weakened immune systems or lung problems are more likely to develop serious complications if they become infected. Delays in treatment or diagnosis can lead to further spread of metastasis to different parts of the body.

Dr (Professor) Minu Walia, Senior Director, Max Institute of Cancer Care Eastern Province (Max Patparganj, Vaishali, Noida, Greater Noida), said, “The incidence of metastatic breast cancer (MBC) has been reported in approximately 5% to 25% from various centers In India While the novel coronavirus has caused a lot of havoc in the recent past, breast cancer has remained a prevalent disease and continues to affect the lives of many people.It is important to understand the risk factors and treatment options, along with the importance of early detection of breast cancer to avoid further from the spread of cancer cells to other parts of the body.”

In 2020, breast cancer in women has now overtaken lung cancer to become the leading cause of cancer worldwide. The Covid-19 virus has affected breast cancer patients not only by increasing the chances of infection but also creating a gap in treatment procedures. Therefore, delays in initiating treatment and breast cancer care may lead to the next stage of cancer and to the metastatic stage. Metastatic cancer is the fourth stage of advanced breast cancer that has spread to other parts of the body such as the liver, lungs, brain, or bones, as well as to the lymph nodes.

The introduction of new treatment methods has significantly improved the survival rate of breast cancer patients. But for this early detection and timely treatment is the key to treatment. Therefore, breast self-examination and early referral to a physician are pivotal.

Breast cancer is the second most common type of cancer in women. According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer and caused 685,000 deaths globally, in 2020. In India, 1 woman is diagnosed with breast cancer every 4 minutes and one dies every 8 minutes from breast cancer. Moreover, the effects of delaying treatment due to the epidemiological situation on breast cancer patients can be observed.

Get live stock quotes from BSE, NSE, US market and latest NAV, mutual fund portfolio, see the latest underwriting news, best IPOs, calculate your tax with income tax calculator, see top market gainers, biggest losers and best stock funds. like us Facebook social networking site and follow us Twitter.

Source link

By admin

Leave a Reply

Your email address will not be published.